The Strange Alliance Trying to Remake American Psychiatry
The Department of Health and critical psychiatry activists are hoping [...]
The Department of Health and critical psychiatry activists are hoping [...]
As biologics have increasingly superseded small molecules in the biopharma [...]
Alumis is exploring strategic alternatives for its would-be rival to [...]
Aardvark Therapeutics is planning to unblind data from its phase [...]
“Outliers are what you’re going for,” Model Medicines CEO Daniel [...]
A federal appeals court ruling against the Food and Drug [...]
Andrea Pfeifer, Ph.D., the longtime leader of Swiss neurodegeneration outfit [...]
Eli Lilly has made a six-year, $50 million commitment to [...]
Following an FDA approval in muscle-invasive bladder cancer patients who [...]
As the wave of in vivo CAR-T hype crests, Create [...]